St. Leonard, Canada

Giorgio G Attardo

This inventor holds 1 USPTO granted patent. Top assignee: Biochem Immunosystems Inc.. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Giorgio G Attardo. Retrieved from https://idiyas.com/inventor/giorgio-g-attardo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Antitumor Compounds by Giorgio G Attardo

Introduction

Giorgio G Attardo is a notable inventor based in St. Leonard, CA. He has made significant contributions to the field of cancer treatment through his innovative research and development of antitumor compounds. His work focuses on creating effective pharmaceutical solutions for various types of cancer.

Latest Patents

Attardo holds a patent for "Heteroanthracycline antitumor analogs." This patent describes heterocyclic antitumor compounds that are useful in the treatment of cancer and tumors in vitro. The compounds target several types of cancer, including breast cancer, leukemia, lung cancer, colon cancer, ovarian cancer, renal cancer, CNS cancer, and melanoma. The patent also outlines pharmaceutical compositions and methods for preparing these compounds.

Career Highlights

Throughout his career, Giorgio G Attardo has been dedicated to advancing cancer treatment through innovative research. His work has led to the development of compounds that have the potential to improve patient outcomes in oncology. He is associated with Biochem Immunosystems Inc., where he continues to contribute to the field.

Collaborations

Attardo has collaborated with notable figures in the field, including Bernard Belleau, who is remembered for his contributions to cancer research. Their partnership has fostered advancements in the development of antitumor therapies.

Conclusion

Giorgio G Attardo's work in developing heteroanthracycline antitumor analogs represents a significant advancement in cancer treatment. His innovative approach and dedication to research continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…